US 8420852
Phospholipase A2 inhibitors and their use in treating neurological injury and disease
granted A61PA61P25/00
Quick answer
US patent 8420852 (Phospholipase A2 inhibitors and their use in treating neurological injury and disease) held by The Regents of the University of California expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P25/00